Opko Health (OPK) Expands Entera Partnership for Drug Co-Development

3 weeks ago 15

Miko Ilas

Fri, February 6, 2026 astatine 10:02 AM CST 1 min read

Opko Health Inc. (NASDAQ:OPK) is 1 of the champion stocks nether $3 to put in. On February 4, Opko Health Inc. (NASDAQ:OPK) announced it expanded its concern with Entera Bio Ltd., a institution processing oral peptide and macromolecule replacement therapies, to beforehand the archetypal oral long-acting PTH analog (LA-PTH) attraction for patients with hypoparathyroidism, successful the signifier of a once-daily tablet. The 2 companies person besides jointly decided to accelerate improvement connected this medicine and expect to record an Investigational New Drug (IND) exertion with the U.S. Food and Drug Administration (FDA) successful precocious 2026.

Opko Health (OPK) Expands Entera Partnership for Drug Co-Development

Under the expanded partnership, Opko Health Inc. (NASDAQ:OPK) and Entera volition each clasp a 50% pro rata ownership involvement successful the LA-PTH hypoparathyroidism program. Each institution volition besides beryllium liable for 50% of the program’s improvement costs. The companies support their antecedently announced ownership operation and cost-sharing statement for the oral OXM programme for metabolic and fibrotic disorders, presently acceptable astatine 60% for Opko Health Inc. (NASDAQ:OPK) and 40% for Entera.

Opko Health Inc. (NASDAQ:OPK) is simply a biopharmaceutical and diagnostics institution that provides healthcare services. Its operations are divided into the Diagnostics and Pharmaceuticals segments.

While we admit the imaginable of OPK arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 11 Best Stocks Under $3 to Buy Right Now and 10 Most Undervalued Stocks to Buy and Hold for 5 Years

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.